The State of Regulated-Industry Marketing: 2026 Data Report

Why This Report Exists

Most "industry trend" content in this space is written by agencies to sell services, so the numbers get rounded up and the sources get dropped. This report does the opposite: every statistic below is tied to a named primary source with a publish date and a link. Where the only available number came from an agency's own self-reported data rather than an independent study, we say that explicitly rather than presenting it as a hard statistic. This is a living reference — we will revisit it as new data publishes.

The Treatment Gap Nobody's Marketing To

According to SAMHSA's 2024 National Survey on Drug Use and Health, an estimated 52.6 million people (18.2% of the U.S. population 12 and older) needed substance use treatment in the past year. Only 10.2 million people actually received it — meaning roughly 42.4 million people, about 80.7% of everyone who needed treatment, did not get it. Of the people with unmet need, only a small share (4.4% of adults, 6.7% of adolescents) even believed they needed treatment in the first place, which points to an awareness and stigma problem as much as an access problem. Source: SAMHSA, 2024 NSDUH Highlights (PDF).

What It Actually Costs to Get a Lead

LocaliQ's healthcare search advertising benchmarks (updated January 2026) break out real cost-per-click, conversion rate, and cost-per-lead figures by specialty. The averages vary enormously across the verticals Tridigiam works in:

Addiction recovery stands out: the conversion rate is by far the lowest of any healthcare category LocaliQ tracks, which is a large part of why cost per lead runs nearly double the healthcare average. This is a compliance and trust problem as much as a targeting problem — searchers in this category are often in crisis, comparison-shopping heavily, and wary of aggressive sales tactics. Source: LocaliQ, Healthcare Search Ads Benchmarks (updated Jan 2026). One agency-published estimate worth noting with a caveat: Webserv, an addiction-treatment marketing agency, reports in its own account data that most treatment-center landing pages convert at only 2–3%, well under what it calls a healthcare-wide benchmark — this is self-reported agency data, not an independent study, so treat it as directional rather than authoritative.

Medical Aesthetics Is Growing Fast

The American Society of Plastic Surgeons' 2024 statistics report counted 1,585,878 cosmetic surgical procedures and 2,634,412 total plastic surgery procedures (cosmetic plus reconstructive) performed in the U.S. that year — surgical procedures up about 1% year over year, minimally invasive procedures up about 3%. The top five cosmetic surgical procedures were liposuction, breast augmentation, tummy tuck, breast lift, and eyelid surgery. Source: ASPS, 2024 Plastic Surgery Statistics Report. Grand View Research sizes the U.S. aesthetic medicine market at $37.94 billion in 2023, projected to reach $90.82 billion by 2030 — a 13.4% compound annual growth rate. Source: Grand View Research, U.S. Aesthetic Medicine Market Report. For practices in this space, the growth curve is real, but so is the competition it is attracting — differentiation and trust signals matter more every year, not less.

Telehealth and Behavioral Health Are Still Climbing

FAIR Health's Q1 2026 telehealth tracker found national telehealth utilization rose 10.1% quarter over quarter, and mental health conditions were the top telehealth diagnostic category in every U.S. region and every age group, accounting for 52.1% of all telehealth diagnoses nationally. Source: FAIR Health, Q1 2026 telehealth data release. For behavioral health providers, this is a direct signal that telehealth-friendly intake and scheduling isn't a nice-to-have anymore — it's where a majority-plus share of demand is already showing up.

Compliance Isn't Optional — What Regulators Are Actually Enforcing

Three recent FTC actions are directly relevant to anyone marketing addiction treatment services, and worth reading in full before your next campaign:

FTC v. Evoke Wellness (June 2025) — the company bid on competitor treatment centers' brand names in Google search ads, then had telemarketers impersonate a neutral "centralized admissions office" instead of disclosing they were Evoke's own call center. Settlement: $7 million penalty, suspended to $1.9 million based on financial disclosures, plus a permanent ban on impersonating other companies or bidding on their names. FTC press release.

FTC v. Mercury Marketing and 12 co-defendants (June 2025) — the same brand-bidding-plus-impersonation scheme, still in litigation as of this report. FTC press release.

FTC v. Monument, Inc. (April 2024) — this alcohol-addiction telehealth provider promised "100% confidential" data handling, then shared identifiable health data with Meta and Google through tracking pixels for two years, affecting roughly 84,000 users. Settlement: a ban on disclosing health data for ad purposes without explicit consent, mandatory deletion requests to third parties, user notification, and a $2.5 million suspended civil penalty. FTC press release.

We looked specifically for a comparable recent FTC or state case against medical spa or aesthetics marketing and could not find a verifiable one from 2024–2026. That does not mean aesthetics marketing carries no regulatory risk — FTC endorsement/testimonial rules and state medical board advertising rules still apply — it means the highest-profile recent enforcement pattern happens to be concentrated in addiction treatment specifically.

HIPAA and Tracking Technology: Where Things Actually Stand

HHS OCR's December 2022 bulletin restricting tracking pixels and analytics on healthcare websites was vacated by a federal court in June 2024 (American Hospital Association v. HHS), and OCR withdrew its appeal two months later. Practically, that means tracking tools like the Meta Pixel or Google Analytics can generally be used on unauthenticated, public-facing pages without violating that specific bulletin. It does not mean tracking is risk-free: authenticated pages (patient portals, secure scheduling) still carry HIPAA and business-associate-agreement obligations, state privacy and wiretap laws can still apply, and — as the Monument case above shows — the FTC can and does pursue tracking-technology misuse as a deceptive-practices matter entirely separate from HIPAA. "The OCR bulletin is gone" is not the same as "tracking carries no risk."

How Patients Actually Research Care Now

Google AI Overviews now appear on the large majority of healthcare searches, but coverage varies sharply by specialty. BrightEdge's research (December 2025) found AI Overview coverage grew from 59% in 2023 to 89% in 2025 across healthcare keywords generally — but for mental health and behavioral health queries specifically, coverage sits at just 63%, notably lower than categories like cardiology (96%) or urology (96%). Source: BrightEdge. On the consumer side, Rock Health's 2025 survey (fielded with 8,000 U.S. adults) found 32% of respondents have used an AI chatbot for health information, double the prior year's 16%, and 40% of AI users went on to consult a real healthcare provider afterward. Source: Rock Health, 2025 Consumer Adoption Survey. Separately, rater8's 2025 patient-choice survey found 84% of patients check online reviews before booking care and 31% now use generative AI specifically to research or compare providers. Source: rater8, 2025 Report.

What This Means If You Market in These Verticals

None of this data points to a single silver-bullet tactic, and we're not going to pretend otherwise. What it does point to: lead cost and conversion rate vary enormously by specialty, so benchmarking against generic "healthcare marketing" averages will mislead you; regulators are actively enforcing against brand-bidding and impersonation schemes in addiction treatment specifically, so campaign structure matters as much as ad copy; behavioral health search visibility inside AI answer engines lags other specialties, which is either a risk or an opening depending on how you approach it; and patients increasingly research providers through a mix of reviews and AI tools before they ever fill out a contact form, which is exactly the kind of multi-touch journey that's impossible to optimize without real attribution data connecting your ad spend to what actually converts. We built The Attribution Stack for that last problem specifically, and we structure every client engagement the way we describe on how we work — month-to-month, with you owning your own data. We are not going to tell you a stat from this report guarantees a particular result for your practice; it does not, and any agency claiming otherwise should make you nervous.

Sources and Methodology

Every statistic in this report was independently verified against its primary source as of publication. Sources used: SAMHSA 2024 NSDUH; LocaliQ Healthcare Search Ads Benchmarks (Jan 2026); Webserv rehab landing page benchmarks (agency-published, self-reported, cited with that caveat); LegitScript addiction treatment certification requirements; FAIR Health telehealth tracker (Q1 2026); ASPS 2024 Plastic Surgery Statistics Report; Grand View Research U.S. Aesthetic Medicine Market Report; FTC press releases (Evoke Wellness, Mercury Marketing, Monument Inc.); federal court ruling in American Hospital Association v. HHS and related legal/compliance-press coverage; BrightEdge healthcare AI Overview research; Rock Health 2025 Consumer Adoption Survey; rater8 2025 Report. Where we could not independently verify a statistic — a dedicated "state of rehab marketing" industry study, a specific LegitScript-certified-provider count, or a recent aesthetics-specific FTC enforcement case — we said so directly rather than including an unverified figure. This report will be updated as new primary-source data publishes.

Frequently Asked Questions

How often does substance use treatment go unmet in the U.S.?

According to SAMHSA's 2024 National Survey on Drug Use and Health, about 52.6 million people needed substance use treatment in the past year, but only about 10.2 million received it, leaving roughly 80.7% of people with a treatment need unmet.

Why is the cost per lead so much higher for addiction treatment than other healthcare categories?

LocaliQ's healthcare search advertising benchmarks show addiction recovery has a conversion rate of just 0.50%, far below other healthcare categories, which drives cost per lead to roughly $120 versus a healthcare-wide average near $66. Searchers in this category are often comparison-shopping heavily and are wary of aggressive sales tactics, which suppresses conversion even when click volume is healthy.

Is HIPAA guidance on website tracking pixels still in effect?

HHS OCR's 2022 bulletin restricting tracking technologies on healthcare websites was vacated by a federal court in June 2024 in American Hospital Association v. HHS, and OCR withdrew its appeal. Tracking tools can generally be used on unauthenticated, public-facing pages, but authenticated pages and other privacy laws still carry separate obligations, and the FTC can still pursue tracking misuse as a deceptive-practices matter.

What FTC enforcement actions have targeted addiction treatment marketing recently?

In 2025 the FTC settled with Evoke Wellness ($1.9 million) and sued Mercury Marketing and 12 co-defendants, both over schemes bidding on competitor treatment centers' brand names and impersonating their admissions lines. In 2024 the FTC settled with Monument, Inc. over sharing confidential health data with Meta and Google through tracking pixels despite promising full confidentiality.

How many patients now use AI tools like ChatGPT to research healthcare providers?

Rock Health's 2025 survey found 32% of respondents have used an AI chatbot for health information, double the prior year's 16%. Separately, rater8's 2025 patient-choice survey found 31% of patients use generative AI tools specifically to research or compare healthcare providers, and 84% check online reviews before booking care.